does glp 1 reduce insulin resistance GLP-1 Agonists - What is it? The central and peripheral effects

Description

9,10 These actions change eating behaviour: the anticipatory food reward for looking forward to eating certain (delicious) foods decreases, while consummatory food reward (the pleasure offered by eating) increases

Now that we understand how central to our health, having extra weight is, and the potential of improving health outcomes (heart disease, cancer, brain disease, kidney disease, liver disease etc) through the reduction of weight, the path is wide open for pharma and biotech companies to develop and market such drugs

Some patients taking these medications have said they feel less interest in alcohol or nicotine

doi: 10.1523/JNEUROSCI.5412-09.2010, 133

the study's lead author and a professor of radiology in the University of Pennsylvania Perelman School of Medicine, said in a statement that the findings were "observational" and do not "definitively confirm an association between GLP-1 medications and reduced breast cancer incidence," however the study "does add to the growing body of evidence suggesting that it's worth investigating these weight-loss drugs as potential cancer prevention tools." Narula reiterated that the new study is "hypothesis-generating" not "practice-changing," though the study does add to a growing body of similar research